The ratings downgrade is based on a number of factors, including the bank’s credit worthiness, the direct-pay letter of credit provided to the health system by the bank and the structure and legal protections of the transaction.
Moody’s Investors Service also affirmed the “VMIG1” short-term rating on the health system’s series 1998A multimodal revenue bonds.
Editor’s note: This article initially reported MedStar Health in Columbia, Md., received a credit downgrade from “Aa2” to “Aa1” from Moody’s. This downgrade pertained to a specific bond, not the health system. Becker’s regrets the error.
More articles on healthcare finance:
Fitch affirms ‘BBB+’ rating on Silver Cross Health System’s bonds
Fitch affirms ‘BB+’ rating on Marshall Medical Center’s bonds
Moody’s affirms ‘A1’ rating on Children’s National Medical Center’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
